Department of Radiology, University of Michigan Health System, 1500 E. Medical Center Dr B2-A209P, Ann Arbor, MI 48109; Michigan Radiology Quality Collaborative, Ann Arbor, Michigan.
Department of Radiology, University of Michigan Health System, 1500 E. Medical Center Dr B2-A209P, Ann Arbor, MI 48109; Department of Urology, University of Michigan Health System, Ann Arbor, Michigan.
Acad Radiol. 2018 Feb;25(2):209-212. doi: 10.1016/j.acra.2017.09.021. Epub 2017 Nov 23.
We aimed to determine the frequency and clinical significance of homogeneous renal masses measuring 21-39 Hounsfield units on contrast-enhanced computed tomography (CT).
Subjects 40-69 years old undergoing portal-venous-phase contrast-enhanced abdominal CT from January 1, 2006 to December 31, 2010 with slice thickness ≤5 mm and no prior CT or magnetic resonance imaging were identified (n = 1387) for this institutional review board-approved retrospective cohort study. Images were manually reviewed by three radiologists in consensus to identify all circumscribed homogeneous renal masses (maximum of three per subject) ≥10 mm with a measured attenuation of 21-39 Hounsfield units. Exclusion criteria were known renal cancer or imaging performed for a renal indication. The primary outcome was retrospective characterization as a clinically significant mass, defined as a solid mass, a Bosniak IIF/III/IV mass, or extirpative therapy or metastatic renal cancer within 5 years' follow-up.
Eligible masses (n = 74) were found in 5% (63/1387) of subjects. Of those with a reference standard (n = 42), none (0% [95% CI: 0.0%-8.4%]) were determined to be clinically significant.
Incidental renal masses on contrast-enhanced CT that are homogeneous and display an attenuation of 21-39 Hounsfield units are uncommon in patients 40-69 years of age, unlikely to be clinically significant, and may not need further imaging evaluation. If these results can be replicated in an independent and larger population, the practical definition of a benign cyst on imaging may be able to be expanded.
本研究旨在确定在增强 CT 上测量的 21-39 亨氏单位的均质肾脏肿块的频率和临床意义。
本回顾性队列研究经机构审查委员会批准,对 2006 年 1 月 1 日至 2010 年 12 月 31 日期间进行门静脉期增强腹部 CT 检查的 40-69 岁的患者进行了研究,CT 层厚≤5mm,且无先前的 CT 或磁共振成像。对所有边界清楚的均质肾脏肿块(每个患者最多三个)进行手动审查,这些肿块的直径≥10mm,CT 值为 21-39 亨氏单位。排除标准为已知的肾癌或出于肾脏原因进行的影像学检查。主要结局为回顾性特征为临床显著肿块,定义为实性肿块、Bosniak IIF/III/IV 肿块、切除治疗或转移性肾癌,并在 5 年内进行随访。
在 5%(63/1387)的患者中发现了符合条件的肿块(n=74)。在有参考标准的患者中(n=42),没有患者(0%[95%CI:0.0%-8.4%])被确定为临床显著。
40-69 岁患者增强 CT 上偶然发现的均质且 CT 值为 21-39 亨氏单位的肾脏肿块不常见,不太可能具有临床意义,可能不需要进一步的影像学评估。如果这些结果可以在独立的更大人群中得到复制,那么影像学上良性囊肿的实用定义可能可以得到扩展。